BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: K Bhanumathy K, Balagopal A, Vizeacoumar FS, Vizeacoumar FJ, Freywald A, Giambra V. Protein Tyrosine Kinases: Their Roles and Their Targeting in Leukemia. Cancers (Basel) 2021;13:E184. [PMID: 33430292 DOI: 10.3390/cancers13020184] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Chen L, Kong X, Fang Y, Paunikar S, Wang X, Brown JAL, Bourke E, Li X, Wang J. Recent Advances in the Role of Discoidin Domain Receptor Tyrosine Kinase 1 and Discoidin Domain Receptor Tyrosine Kinase 2 in Breast and Ovarian Cancer. Front Cell Dev Biol 2021;9:747314. [PMID: 34805157 DOI: 10.3389/fcell.2021.747314] [Reference Citation Analysis]
2 De Sepulveda P, Pasquet JM. Protein Kinases in Leukemias. Cancers (Basel) 2021;13:2747. [PMID: 34206000 DOI: 10.3390/cancers13112747] [Reference Citation Analysis]
3 Ancos-Pintado R, Bragado-García I, Morales ML, García-Vicente R, Arroyo-Barea A, Rodríguez-García A, Martínez-López J, Linares M, Hernández-Sánchez M. High-Throughput CRISPR Screening in Hematological Neoplasms. Cancers (Basel) 2022;14:3612. [PMID: 35892871 DOI: 10.3390/cancers14153612] [Reference Citation Analysis]
4 Gao J, Xu G, Xu P. Gills full-length transcriptomic analysis of osmoregulatory adaptive responses to salinity stress in Coilia nasus. Ecotoxicol Environ Saf 2021;226:112848. [PMID: 34619476 DOI: 10.1016/j.ecoenv.2021.112848] [Reference Citation Analysis]
5 Zhang B, Xu Z, Liu Q, Xia S, Liu Z, Liao Z, Gou S. Design, synthesis and biological evaluation of cinnamamide-quinazoline derivatives as potential EGFR inhibitors to reverse T790M mutation. Bioorg Chem 2021;117:105420. [PMID: 34655841 DOI: 10.1016/j.bioorg.2021.105420] [Reference Citation Analysis]
6 Catara G, Spano D. Combinatorial Strategies to Target Molecular and Signaling Pathways to Disarm Cancer Stem Cells. Front Oncol 2021;11:689131. [PMID: 34381714 DOI: 10.3389/fonc.2021.689131] [Reference Citation Analysis]
7 Elkamhawy A, Lu Q, Nada H, Woo J, Quan G, Lee K. The Journey of DDR1 and DDR2 Kinase Inhibitors as Rising Stars in the Fight Against Cancer. Int J Mol Sci 2021;22:6535. [PMID: 34207360 DOI: 10.3390/ijms22126535] [Reference Citation Analysis]
8 Spinello Z, Fregnani A, Quotti Tubi L, Trentin L, Piazza F, Manni S. Targeting Protein Kinases in Blood Cancer: Focusing on CK1α and CK2. Int J Mol Sci 2021;22:3716. [PMID: 33918307 DOI: 10.3390/ijms22073716] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Salimi-Jeda A, Ghabeshi S, Gol Mohammad Pour Z, Jazaeri EO, Araiinejad M, Sheikholeslami F, Abdoli M, Edalat M, Abdoli A. Autophagy Modulation and Cancer Combination Therapy: A Smart Approach in Cancer Therapy. Cancer Treat Res Commun 2022;30:100512. [PMID: 35026533 DOI: 10.1016/j.ctarc.2022.100512] [Reference Citation Analysis]